NCT02470455View on ClinicalTrials.gov

Effect of Atorvastatin on Glycemic Control in Prediabetic Patients

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Prediabetic State
Interventions
DRUG

Atorvastatin

Some patients were receiving 20 mg of Atorvastatin wheras others were on a higher dose of 40-80mg daily. Patients were taking statins for either dyslipidemia, or primary or secondary prevention of cardiovascular disease.

Trial Locations (1)

752001

SCB Medical College, Cuttack

All Listed Sponsors
lead

Shri Ramachandra Bhanj Medical College

OTHER

NCT02470455 - Effect of Atorvastatin on Glycemic Control in Prediabetic Patients | Biotech Hunter | Biotech Hunter